Japan’s high-quality health data and innovations present opportunities between Japan and the UK

By Catherine Sturman
As the world’s third largest economy, Japan is leading the way for aging societies. This transformative initiative has significant implementations for...

As the world’s third largest economy, Japan is leading the way for aging societies. This transformative initiative has significant implementations for the economic growth of the UK, representing immense business opportunities as its population also ages.

This was the takeaway of an engaging discussion between a group of more than 20 experts from established research institutions, innovative digital health companies and leading media of the UK and Japan at a roundtable event held in London on 20 November.

The event "Open for Business: Capitalising on Japan’s Digital Healthcare Economy during this Era of Aging Societies" hosted by the Government of Japan and moderated by Martin Koehring, Managing Editor and Global Healthcare Lead, Thought Leadership, The Economist Intelligence Unit, featured Professor Sudhesh Kumar Dean of the Warwick Medical School and Non-Executive Director at NHS Digital, Shinsuke Muto, Chairman, Integrity Healthcare Co., Ltd., Yumiko Nishimura, Advisor-Japan, Health 2.0/HIMSS and Kazumi Nishikawa, Director, Healthcare Industries Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry of Japan, who joined via video conference from Japan.

One-fifth of Japan’s citizens are 70 years of age or older, putting it at the forefront of demographic changes now facing many other developed nations, including the UK. Taking this unprecedented challenge of a super-aging society as a transformative opportunity, the Government of Japan is working on implementing a new patient-oriented healthcare system by 2020.

This initiative, which includes data and technological innovations to promote healthier lifestyles, provides strong opportunities for the UK to collaborate with Japan across many areas of healthcare innovation, such as the Internet of Things and Artificial Intelligence.

At the event, speakers discussed how Japan is well placed to serve as the world’s test bed for the emerging digital healthcare economy in this era of aging societies; the country’s high-quality data around medical, health and long-term care, generated from the country’s universal healthcare system covering its 127mn citizens, is hugely attractive to scientists and businesses.

See also

 Advanced technology including Artificial Intelligence and the Internet of Things, coupled with the data, is spurring new business creation, which delivers healthcare more effectively and efficiently for the countries sharing the same demographic change, including the UK.

“The amazing increase in our life expectancy comes with both opportunities and challenges. An ageing population means increased healthcare costs, later retirement, and a need for research and development to prevent and treat more chronic diseases.

For Japan, the UK and other countries to address this challenge, collaboration is key. We must work together to create a global healthcare ecosystem, where research, innovation and information sharing support better services, delivery and outcomes.” – Professor Sudhesh Kumar, Dean of the Warwick Medical School, Non-Executive Director at NHS Digital

"There are many areas Japan can work together with the UK for realising life-long active societies through open innovation. I expect further collaboration with UK companies and research institutions for value-added market creation, to solve our shared issues going forward." – Kazumi Nishikawa, Director, Healthcare Industries Division, Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry of Japan.

The event, "Open for Business: Capitalising on Japan’s Digital Healthcare Economy during this Era of Aging Society," was supported by the Japan Agency for Medical Research and Development (AMED) and the Japan External Trade Organization (JETRO) London.

"Open for Business" roundtable discussions will take place in Europe with events in Munich (November 21) and Paris (November 22).

The Government of Japan continues to transform its market into a high quality business environment to meet the needs of worldwide businesses by providing world-leading, high-value business environment that enables companies to expand and thrive. The country is generating new and exciting opportunities in an economy that is aligning its regulations with those of other advanced economies to enable seamless transition for companies ready to expand into new growth markets.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare